If you market a hospital, a health system or a digital health product, you work under a constraint most AEO advice skips. Other verticals can afford a sloppy first draft. Yours can't. Publish one unverified drug interaction claim, or a testimonial with a stray identifying detail, and you're facing HIPAA fines or FTC letters, or worse. Publish nothing, and Mayo Clinic and Cleveland Clinic quietly take every citation your brand should be earning.
That's why I'd call healthcare the hardest vertical in AI search, and the technology isn't the reason. A HIPAA-safe way to do AEO does exist. It just looks nothing like the SaaS version, because your pages have to satisfy what AI models cite and what compliance permits, plus what YMYL now requires. Lay those rules side by side and they point to one very specific playbook.
Who actually gets cited for medical queries
Start with the competition, because it's mostly three hospital brands. Everything-PR's Healthcare Citation Share Index 2026 put 75-plus consumer, clinician and procurement queries to ChatGPT, Claude and Gemini, and to Perplexity and Google AI Overviews as well. The citation share came out like this:
| Source | Share of healthcare citations |
|---|---|
| Mayo Clinic | 9.4% |
| Cleveland Clinic | 7.1% |
| Johns Hopkins | 6.8% |
| Those three combined | 23.3% |
| The entire pharma category | 21.6% |
| Consumer platforms (WebMD, Healthline, Drugs.com, GoodRx) | 16.2% |
| NIH and MedlinePlus | 5.2% |
The combined row is the one I'd show your leadership. Three hospital brands take more of the citations than every pharma company put together. NIH and MedlinePlus deserve a look too, because they reach 5.2% with a far smaller web presence than the commercial sites.
The engines don't agree on much past that. Outcomes Rocket's study of 5,472 citations found their patterns diverging sharply:
| Engine | Citations per answer | What it favors |
|---|---|---|
| Perplexity | 14.97 | Commercial and consumer health platforms |
| Claude | 13.99 | Primary research, approaching parity |
| ChatGPT | 13.59 | Health media and the Mayo/Cleveland/Hopkins triumvirate |
| Gemini | 12.29 | Government and NGO sources |
Perplexity cites the most sources per answer, and on March 19, 2026, it launched Perplexity Health, with Apple Health and EHR integration via b.well. If your team publishes research, watch Claude. PubMed Central was the single most-cited source in the whole dataset.
That study also says something about the kind of page that gets picked:
| What the cited content had in common | Share of citations |
|---|---|
| High-authority domain (DR 81-100) | 62.4% |
| Openly accessible | 99.3% |
| Dated 2024 or 2025 | About two-thirds |
The 99.3% is the figure I'd act on first. Paywalled research doesn't get cited, so outcomes data that sits behind a journal paywall does nothing for you here. And with about two-thirds of the cited pages dated 2024 or 2025, recency matters more in healthcare than in almost any other vertical.
The HIPAA filter that kills most healthcare content plans
Most healthcare content plans die here, usually because someone drafted them the way you'd draft SaaS content. The SaaS habits show up fast: a patient testimonial with a name on it, or a personal story doing the job of social proof. Condition-specific landing pages get tracked URL parameters. Every one of those is a HIPAA question.
Tracking is where the money has gone. OCR's 2023 interpretation of tracking technology has already produced $100M-plus in settlement fines for healthcare organizations that let pixels, session replays and analytics collect data on condition-specific pages. OCR's current reading reaches a long way. If you're a covered entity, even the IP address of someone reading a condition-specific article on your site can qualify as PHI.
This year's list won't make it easier. OCR's 2026 enforcement priorities put risk analysis at the top, and it now explicitly covers AI systems, with tracking technology and Business Associate Agreements right beside it.
The HIPAA blind spot in AI Agents that nobody is talking about.
In Healthcare IT, we are trained to treat every piece of data as sensitive. We encrypt databases, mask logs, and lock down APIs. But the new wave of "AI Agents" is creating a new category of vulnerability that standard firewalls can't see....
That r/HealthTech thread explains the risk better than most compliance decks. A healthcare developer wrote about HIPAA blind spots in AI agents, and practitioners reacted sharply because it named a gap most compliance frameworks miss: PII filters that check the user's prompt and never the tool's response. Your content has its own version of that gap. A page can pass legal review on its own and still re-identify a patient once someone combines it with other public data, and diagnosis plus geography plus rare treatment timing is often enough.
Sort every content idea into one of these two columns before anyone writes a word:
| HIPAA-safe for AEO content | Kills a healthcare AEO plan |
|---|---|
| Fully de-identified statistics under the 18-element Safe Harbor rule or an Expert Determination method | Patient testimonials that combine diagnosis with outcome, timing, and location |
| General condition and treatment education with no patient-specific connection | Condition-specific URL parameters that reveal patient intent |
| Aggregate outcomes data with no individual traceability | Third-party trackers on any page where a user enters health information |
| Published peer-reviewed research already in the public record | AI-generated medical content with no clinician review |
| Clinician bylines and credentials, which are professional data | Uploading real patient data into public AI tools without a signed BAA |
If you want one model that passes, use composite personas that you openly disclose as composites. Pair them with aggregate statistics, and have a clinical reviewer sign off that no real patient is identifiable.
Built by the team that got cited in 48 hours.
Content generation, backlink building, AI visibility tracking, and Google rankings. One platform, zero guesswork.
The YMYL bar just moved higher
Google's December 2025 Core Update hit Healthline, Medical News Today and WebMD with what Glenn Gabe documented as "steep visibility drops." In his analysis, the medical content that survived had named credentialed authors and a separate medical reviewer byline. Its reviews were dated, and it referenced named clinical guideline bodies explicitly.
It's not often you see a site doing extremely well in ChatGPT without strong Google rankings, which is why I had to dig into this case -> Surging in ChatGPT, Dead in Google – The curious case of a YMYL site with no search visibility in Google, but cited like crazy in ChatGPT The https://t.co/KiyAU5xWOK
Glenn Gabe@glenngabeJun 22, 2026
His YMYL case study of a site "surging in ChatGPT" while it was dead in Google deserves a second read. I don't take it to mean AI engines are lax. Google and the AI engines use different authority signals right now, and that gap is closing. Sites that got by on AI citations with weak E-E-A-T are watching their citation share erode as the engines add YMYL-style filtering.
For medical AEO, E-E-A-T now comes down to six signals you can point to on the page:
| Signal | What it looks like |
|---|---|
| Named author | Credentials (MD, DO, PharmD, NP, RN), specialty, board certifications and professional affiliations, near the top of the page rather than in a footer bio |
| Separate medical reviewer | A byline with the reviewer's credentials, the review date, and a specialty matched to the topic (a cardiologist reviews cardiology content) |
| Institutional signals | Hospital affiliation, medical school, professional organization memberships |
| Named guideline citations | Body and year (USPSTF, AHA, ACC, WHO, CDC), not vague "medical experts recommend" phrasing |
| Claim classification | Established evidence kept separate from emerging research, using hedging language ("studies suggest," "current guidelines recommend") instead of absolutes ("proven," "guaranteed") |
| Documented review schedule | Quarterly for oncology and infectious disease, annually for foundational content |
If your author bio lives in the footer, move it near the top of the page. Each row in that table works twice for you, as a Google ranking factor and as a trust input for AI citations. The same signals matter when Google's summaries get a health topic wrong, which we cover in our piece on AI Overviews and health advice.
The medical schema stack that moves citations
FAQ schema is the baseline in every vertical. In healthcare you add medical schema on top, and MedicalWebPage is the primary type for any medical content page. It carries the three properties AI engines read as signs of editorial oversight: lastReviewed, reviewedBy and medicalAudience. Ship a page with those filled in and it looks meaningfully different to a retrieval layer.
This is the full stack I'd implement:
| Schema type | Use it on | Properties to populate |
|---|---|---|
| MedicalWebPage | Every medical article | reviewedBy, lastReviewed, medicalAudience, specialty |
| MedicalCondition | Condition pages | associatedAnatomy, possibleTreatment, riskFactor, signOrSymptom |
| Drug | Medication pages | activeIngredient, prescriptionStatus, administrationRoute |
| MedicalTest | Diagnostic content | |
| MedicalGuideline | Content linked to specific practice guidelines by issuer | |
| MedicalStudy | Claims tied to specific trials | |
| MedicalOrganization | The health entity itself | medicalSpecialty, hospitalAffiliation |
| Physician | Individual clinician profiles |
Google AI Overviews now appears for a large share of medical queries, and its citation logic treats pages without MedicalWebPage markup as generic blog content. That's a poor place for a clinically reviewed page to land. For the robots.txt and directive syntax underneath all this, our complete robots.txt directive reference covers what to allow for each vendor's crawler.
See your first AI citation report in under 5 minutes.
No setup calls. No onboarding meetings. Connect your domain and see where AI mentions your brand right now.
Off-site presence: what ranks a health brand beyond the website
Off-site signals do more of the work in healthcare than in any other vertical. AI engines weight third-party validation heavily, and the mix that counts for medical brands is unusual. This is the order I'd tackle it in:
| Priority | Off-site property | Detail |
|---|---|---|
| 1 | PubMed and PubMed Central indexing | IRB-approved outcomes research indexed in PubMed |
| 2 | Doximity profiles for individual clinicians | Complete, with specialty, affiliation and publication history |
| 3 | Consistent entity data across directories | Google Business Profile, Healthgrades, Zocdoc, hospital affiliation directories, insurance network directories, state medical board listings |
| 4 | Wikipedia presence for major health systems | With properly sourced citations |
| 5 | Syndication to Medscape or HealthDay | Among the high-DA domains AI engines preferentially cite |
For a digital health SaaS or a health system, the top row is the prize. PMC was the single most-cited specific source in the Outcomes Rocket dataset, and IRB-approved outcomes research indexed in PubMed is the single highest-impact AEO asset you can have.
Doximity is the primary U.S. physician network, and its own report found 63% of U.S. physicians using AI in practice by early 2026. When your clinicians complete their profiles, their authority signal gets stronger, and that cascades to your brand.
The directory cleanup is boring, and it's where most health brands lose citation share to competitors who already did it. The whole trick is standardization. Your legal name, your address format and your specialty taxonomy should be identical in every listing.
The MLR sign-off workflow for AEO content
Pharma teams have run MLR (Medical, Legal, Regulatory) review for a decade. Your AEO content needs the same discipline, adapted to the shorter cadence AI-visibility content demands. I'd run it in six stages:
| Stage | Owner | What happens |
|---|---|---|
| 1. Content brief | SEO strategist or editor | Defines patient intent, target AEO queries and claim scope |
| 2. Draft | Health writer, ideally with a healthcare journalism background | Produces the copy and tags every claim with its source guideline or study at draft time |
| 3. Editorial review | Managing editor | Checks clarity, claim consistency and scope-of-applicability framing |
| 4. Clinical review | Licensed medical reviewer matched to the topic (MD, DO, PharmD, NP or RN of the correct specialty) | Validates accuracy and alignment with current guidelines |
| 5. Compliance and legal check | Legal or compliance team | Reviews FDA and FTC language, HIPAA implications and risk exposure |
| 6. Scheduled refresh | Quarterly for fast-moving topics like oncology and infectious disease, annually for foundational content |
At stage four, add one test that's specific to AEO. Take any sentence on the page and imagine an AI engine quoting it with no context around it. Does it survive scrutiny? If it doesn't, rewrite it, because that's effectively the standard the citation layer enforces.
Documentation matters just as much. Keep the author's and reviewer's names and credentials in the document record, along with review dates and methodology. Add a version history that says what changed, and cite guideline versions with their year. Compliance auditors and AI engines reward the same signal here, which is a paper trail of qualified review.
Your competitors are building backlinks while you read this.
Organic outreach, social mentions, and link exchanges, with managed backlinks available as an add-on. Grow your domain authority without running the campaign yourself.
Healthcare AEO looks slow at the start because it is slow. Three months of MLR-reviewed content and structured data work will bring you less traffic than three months of ungated SaaS content would. What you get in exchange is a position that holds once your brand enters Mayo Clinic's and Cleveland Clinic's citation pool.
AI engines reward exactly the signals that HIPAA, YMYL and FTC substantiation already ask of you. The regulatory constraints that feel like a tax on your marketing are the same signals that get you cited. So I'd run compliance and AEO as one process. Split them and you'll run neither well, and no third option survives an OCR audit or a Perplexity ranking refresh.
If you want the vocabulary down before your next MLR review, our AEO terminology cheat sheet has 65 terms defined in one line each. And RankControl checks your tracked queries across six engines every week.
